EisnerAmper Wealth Management Corporate Benefits’s Teva Pharmaceuticals TEVA Stock Holding History

EisnerAmper Wealth Management Corporate Benefits’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-4,382	Closed	-$247K	–	68
2015 Q3	$247K	Sell	4,382 -3,624	-45%	-$235K	0.17%	104
2015 Q2	$473K	Sell	8,006 -3,907	-33%	-$241K	0.36%	54
2015 Q1	$742K	Buy	11,913 +583	+5%	+$33.9K	0.56%	30
2014 Q4	$651K	Buy	+11,330	New	+$631K	0.52%	42

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

EisnerAmper Wealth Management Corporate Benefits's TEVA Position: Q4 2015 in Review

EisnerAmper Wealth Management Corporate Benefits sold out of Teva Pharmaceuticals (TEVA) in Q4 2015, closing a stake of 4,382 shares — an estimated $247K sold.

EisnerAmper Wealth Management Corporate Benefits first reported a position in TEVA in Q4 2014 and held it in 4 quarters. The position peaked at $742K in Q1 2015. 876 funds tracked by Wall St. Rank hold TEVA as of Q4 2015.

EisnerAmper Wealth Management Corporate Benefits reported no remaining Teva Pharmaceuticals position as of Q4 2015 after selling out during the quarter.
EisnerAmper Wealth Management Corporate Benefits sold 4,382 Teva Pharmaceuticals shares in Q4 2015, an estimated $247K.
EisnerAmper Wealth Management Corporate Benefits first reported a position in Teva Pharmaceuticals in Q4 2014 and held it in 4 quarters.
EisnerAmper Wealth Management Corporate Benefits's Teva Pharmaceuticals position peaked at $742K in Q1 2015.
876 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2015.

Based on EisnerAmper Wealth Management Corporate Benefits's 13F filing for Q4 2015, filed 4 Jan 2016.